Syntropharma is an emerging pharmaceutical company focussed on taking commercially successful generic compounds and improving their clinical profile by reformulating them as patch applications which are applied to the skin. Its vision is to develop a stream of first and second to market transdermal products with strong IP that will be out-licensed to pharmaceutical company partners.
Funding Rounds (2) - $2.6MUpdate
Tweed Horizons Business Centre
St Boswells, TD6 0SG